JP Morgan Chase
DERM icon

JP Morgan Chase’s Journey Medical DERM Stock Holding History

JP Morgan Chase’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Sell
294
-8,172
-97% -$46.7K ﹤0.01% 7226
2026
Q1 		$37.2K Buy
8,466
+2,627
+45% +$20.4K ﹤0.01% 6313
2025
Q4 		$45K Buy
5,839
+900
+18% +$7.06K ﹤0.01% 6273
2025
Q3 		$35.2K Sell
4,939
-797
-14% -$5.78K ﹤0.01% 6337
2025
Q2 		$41.2K Buy
+5,736
New +$39.6K ﹤0.01% 5986
2024
Q4 		– Sell
-469
Closed -$2.65K – 7447
2024
Q3 		$2.65K Buy
469
+449
+2,245% +$2.31K ﹤0.01% 6588
2024
Q2 		$113 Buy
20
+5
+33% +$21 ﹤0.01% 6862
2024
Q1 		$55 Sell
15
-97
-87% -$422 ﹤0.01% 7014
2023
Q4 		$645 Buy
112
+105
+1,500% +$468 ﹤0.01% 6894
2023
Q3 		$19 Buy
+7
New +$16 ﹤0.01% 7175

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

JP Morgan Chase's DERM Position: Q2 2026 in Review

JP Morgan Chase reduced its Journey Medical (DERM) stake by 97% in Q2 2026, selling an estimated $46.7K and leaving 294 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #7226.

JP Morgan Chase first reported a position in DERM in Q3 2023 and has held it in 10 quarters since. The position peaked at $45K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • JP Morgan Chase held 294 shares of Journey Medical worth $2K as of Q2 2026.
  • JP Morgan Chase sold 8,172 Journey Medical shares in Q2 2026, an estimated $46.7K.
  • Journey Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7226 holding.
  • JP Morgan Chase first reported a position in Journey Medical in Q3 2023 and has held it in 10 quarters since.
  • JP Morgan Chase's Journey Medical position peaked at $45K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.